Evidence map›Paper›PMID 34813702›Full record

ArticleAnalytical chemistry2021

Influenza AM2 Channel Oligomerization Is Sensitive to Its Chemical Environment.

Julia A Townsend, Henry M Sanders, Amber D Rolland, Chad K Park, Nancy C Horton, James S Prell, Jun Wang, Michael T Marty

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Design of Fluorescent Membrane Scaffold Proteins for Nanodiscs.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. The Role of Cholesterol in M2 Clustering and Viral Budding Explained.Journal of chemical theory and computation · 2025
    Article
  6. Expanding Native Mass Spectrometry to the Masses.Journal of the American Society for Mass Spectrometry · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Conformation of influenza AM2 membrane protein in nanodiscs and liposomes.Biochimica et biophysica acta. Biomembranes · 2023
    Article
  14. Dissecting the structural heterogeneity of proteins by native mass spectrometry.Protein science : a publication of the Protein Society · 2023
    Review
  15. Antiviral Approaches against Influenza Virus.Clinical microbiology reviews · 2023
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Julia A TownsendDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.
Henry M SandersDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.
Amber D RollandDepartment of Chemistry and Biochemistry, University of Oregon, Eugene, Oregon 97403, United States.ORCID 0000-0002-7905-8250
Chad K ParkDepartment of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721, United States.
Nancy C HortonDepartment of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85721, United States.
James S PrellDepartment of Chemistry and Biochemistry, University of Oregon, Eugene, Oregon 97403, United States.ORCID 0000-0002-7505-9168
Jun WangDepartment of Pharmacology and Toxicology, The University of Arizona, Tucson, Arizona 85721, United States.
Michael T MartyDepartment of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, United States.ORCID 0000-0001-8115-1772
University of Arizona · USUniversity of Oregon · US

Funding

MOLECULAR BIOLOGY AND BIOPHYSICST32GM007759 · NIGMS · UNIVERSITY OF OREGON · PI NOLEN, BRADLEY J · 1985 to 2021
$8.5M
CHEMISTRY-BIOLOGY INTERFACE TRAINING PROGRAMT32GM008804 · NIGMS · UNIVERSITY OF ARIZONA · PI MONTFORT, WILLIAM R. · 2003 to 2023
$3.9M
Unravelling Membrane Protein-Lipid Interactions using Nanodiscs and Mass SpectrometryR35GM128624 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Michael T Marty · 2018 to 2026
$3.6M
Drug Discovery Targeting the Influenza A Virus M2-S31N Proton ChannelR33AI119187 · NIAID · UNIVERSITY OF ARIZONA · PI PEREZ, DANIEL R, WANG, JUN · 2017 to 2019
$1.2M
Mass Spectrometry Analysis of Lipid-Protein Interactions and Structural Heterogeneity in the Anthrax Toxin PoreR21AI125804 · NIAID · UNIVERSITY OF OREGON · PI PRELL, JAMES STEPHEN · 2017 to 2018
$424k
Discovery of broad-spectrum influenza antivirals with a high genetic barrier to drug resistance by targeting the viral polymeraseR21AI144887 · NIAID · UNIVERSITY OF ARIZONA · PI WANG, JUN · 2019 to 2020
$415k
NIAID NIH HHS R21 AI125804NIAID NIH HHS R21 AI144887NIAID NIH HHS R33 AI119187NIGMS NIH HHS R35 GM128624NIGMS NIH HHS T32 GM007759NIGMS NIH HHS T32 GM008804
6 · The paper itself

Abstract

Viroporins are small viral ion channels that play important roles in the viral infection cycle and are proven antiviral drug targets. Matrix protein 2 from influenza A (AM2) is the best-characterized viroporin, and the current paradigm is that AM2 forms monodisperse tetramers. Here, we used native mass spectrometry and other techniques to characterize the oligomeric state of both the full-length and transmembrane (TM) domain of AM2 in a variety of different pH and detergent conditions. Unexpectedly, we discovered that AM2 formed a range of different oligomeric complexes that were strongly influenced by the local chemical environment. Native mass spectrometry of AM2 in nanodiscs with different lipids showed that lipids also affected the oligomeric states of AM2. Finally, nanodiscs uniquely enabled the measurement of amantadine binding stoichiometries to AM2 in the intact lipid bilayer. These unexpected results reveal that AM2 can form a wider range of oligomeric states than previously thought possible, which may provide new potential mechanisms of influenza pathology and pharmacology.

Indexed as

Influenza, HumanAmantadineAntiviral AgentsHumansLipid BilayersViral Matrix ProteinsAmantadineAntiviral AgentsLipid BilayersViral Matrix Proteins

Identifiers

PMID34813702
PMCPMC8665133
OpenAlexW3216722201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.